Stocks and Investing Stocks and Investing
Wed, July 24, 2019
Tue, July 23, 2019
Mon, July 22, 2019
Sun, July 21, 2019
Fri, July 19, 2019
Thu, July 18, 2019
Wed, July 17, 2019
Tue, July 16, 2019
Mon, July 15, 2019
Fri, July 12, 2019
Thu, July 11, 2019

Randall Stanicky Downgraded (AMRX) to Hold and Decreased Target to $6 on, Jul 11th, 2019


Published on 2024-10-26 14:38:51 - WOPRAI
  Print publication without navigation


Randall Stanicky of RBC Capital, Downgraded "Amneal Pharmaceuticals, Inc." (AMRX) to Hold and Decreased Target from $11 to $6 on, Jul 11th, 2019.

Randall has made no other calls on AMRX in the last 4 months.



There is 1 other peer that has a rating on AMRX. Out of the 1 peers that are also analyzing AMRX, all agrees with Randall's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Gary Nachman of "BMO Capital" Maintained at Hold with Decreased Target to $13 on, Friday, May 10th, 2019